SCHEMBL29566298

SCHEMBL29566298

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2cccc(N3CCN(C)CC3)c2)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.41
▸ HTR1A P08908 2/20 0.41
▸ HTR7 P34969 2/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ RAD52 P43351 2/20 0.39
▸ BRD4 O60885 2/20 0.37
▸ GUSB P08236 1/20 0.36
▸ CTSC P53634 2/20 0.36
▸ JAK2 O60674 2/20 0.36
▸ EGFR P00533 4/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ TNK2 Q07912 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.35
▸ F10 P00742 1/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310431 1.00 HTR2C (0.41) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL29567219 0.92 HTR7 (0.42) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL29567356 0.92 RAD52 (0.39) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL24309381 0.92 HTR7 (0.42) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL26808918 0.92 RAD52 (0.39) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL29567464 0.91 HTR1A (0.41) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL26808712 0.91 HTR7 (0.41) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL26808930 0.91 HTR1A (0.41) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL24309842 0.90 CTSC (0.39) HTR2CHTR1AHTR7HTR2ADRD3
SCHEMBL26811481 0.90 HTR2C (0.40) HTR2CHTR1AHTR7HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback